MENU
+Compare
ALVO
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$9.64
Change
-$0.03 (-0.31%)
Capitalization
3.48B

ALVO Alvotech Forecast, Technical & Fundamental Analysis

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more

ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ALVO with price predictions
Apr 01, 2025

ALVO in upward trend: price may ascend as a result of having broken its lower Bollinger Band on March 27, 2025

ALVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 32 cases where ALVO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALVO advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALVO as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ALVO turned negative on March 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for ALVO moved below the 200-day moving average on March 25, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ALVO entered a downward trend on April 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (60.617). P/E Ratio (57.471) is within average values for comparable stocks, (90.174). ALVO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (36.232) is also within normal values, averaging (20.094).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ALVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALVO is expected to report earnings to fall 114.89% to 2 cents per share on May 07

Alvotech ALVO Stock Earnings Reports
Q1'25
Est.
$0.03
Q4'24
Missed
by $0.19
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.59
Q1'24
Missed
by $0.81
The last earnings report on March 26 showed earnings per share of -18 cents, missing the estimate of 0 cents. With 180.80K shares outstanding, the current market capitalization sits at 3.48B.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGEBX67.220.45
+0.67%
American Funds Growth Fund of Amer R2E
DLDRX41.83N/A
N/A
BNY Mellon Natural Resources I
DPREX12.13N/A
N/A
Macquarie Global Listed Real Assets A
DEVLX60.99N/A
N/A
Macquarie Small Cap Value A
ADCYX20.58N/A
N/A
American Century Disciplined Growth Y

ALVO and Stocks

Correlation & Price change

A.I.dvisor tells us that ALVO and AKAN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and AKAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+1.26%
AKAN - ALVO
24%
Poorly correlated
-3.50%
CURLF - ALVO
21%
Poorly correlated
-9.00%
CRON - ALVO
20%
Poorly correlated
+1.12%
ELAN - ALVO
20%
Poorly correlated
+0.86%
PRGO - ALVO
20%
Poorly correlated
-0.07%
More